These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 6330065)

  • 41. Reversible block in intracellular transport and budding of mutant vesicular stomatitis virus glycoproteins.
    Lodish HF; Kong N
    Virology; 1983 Mar; 125(2):335-48. PubMed ID: 6301145
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Specific targeting to CD4+ cells of recombinant vesicular stomatitis viruses encoding human immunodeficiency virus envelope proteins.
    Johnson JE; Schnell MJ; Buonocore L; Rose JK
    J Virol; 1997 Jul; 71(7):5060-8. PubMed ID: 9188571
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sequential transport of protein between the endoplasmic reticulum and successive Golgi compartments in semi-intact cells.
    Schwaninger R; Beckers CJ; Balch WE
    J Biol Chem; 1991 Jul; 266(20):13055-63. PubMed ID: 1649174
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of vesicular stomatitis virus replication by delta 12-prostaglandin J2 is regulated at two separate levels and is associated with induction of stress protein synthesis.
    Pica F; De Marco A; De Cesare F; Santoro MG
    Antiviral Res; 1993 Mar; 20(3):193-208. PubMed ID: 8385894
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of inhibitors of glycoprotein processing on oligodendroglial differentiation in primary cultures of embryonic rat brain cells.
    Bhat NR
    J Neurosci Res; 1988; 20(2):158-64. PubMed ID: 2971819
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of oligosaccharides in the processing and maturation of envelope glycoproteins of human immunodeficiency virus type 1.
    Pal R; Hoke GM; Sarngadharan MG
    Proc Natl Acad Sci U S A; 1989 May; 86(9):3384-8. PubMed ID: 2541446
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cytoplasmic domain requirement for incorporation of a foreign envelope protein into vesicular stomatitis virus.
    Owens RJ; Rose JK
    J Virol; 1993 Jan; 67(1):360-5. PubMed ID: 8093220
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Microinjected antibodies against the cytoplasmic domain of vesicular stomatitis virus glycoprotein block its transport to the cell surface.
    Kreis TE
    EMBO J; 1986 May; 5(5):931-41. PubMed ID: 3013626
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Persistence of vesicular stomatitis virus in cloned interleukin-2-dependent natural killer cell lines.
    Rosenthal KL; Zinkernagel RM; Hengartner H; Groscurth P; Dennert G; Takayesu D; Prevec L
    J Virol; 1986 Nov; 60(2):539-47. PubMed ID: 3021987
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Assembly functions of vesicular stomatitis virus matrix protein are not disrupted by mutations at major sites of phosphorylation.
    Kaptur PE; McKenzie MO; Wertz GW; Lyles DS
    Virology; 1995 Feb; 206(2):894-903. PubMed ID: 7856102
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of swainsonine and castanospermine on the sulfation of the oligosaccharide chains of N-linked glycoproteins.
    Merkle RK; Elbein AD; Heifetz A
    J Biol Chem; 1985 Jan; 260(2):1083-9. PubMed ID: 3918027
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of glycoprotein processing blocks assembly of spicules during development of the sea urchin embryo.
    Kabakoff B; Lennarz WJ
    J Cell Biol; 1990 Aug; 111(2):391-400. PubMed ID: 2143193
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Protective efficacy of a recombinant Newcastle disease virus expressing glycoprotein of vesicular stomatitis virus in mice.
    Zhang M; Ge J; Li X; Chen W; Wang X; Wen Z; Bu Z
    Virol J; 2016 Feb; 13():31. PubMed ID: 26911572
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Secretion of rat hepatic lipase is blocked by inhibition of oligosaccharide processing at the stage of glucosidase I.
    Verhoeven AJ; Jansen H
    J Lipid Res; 1990 Oct; 31(10):1883-93. PubMed ID: 2150412
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of deoxymannojirimycin and castanospermine on the polarized secretion of thyroglobulin.
    Franc JL; Giraud A; Lanet J
    Endocrinology; 1990 Mar; 126(3):1464-70. PubMed ID: 2137773
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Foreign glycoproteins expressed from recombinant vesicular stomatitis viruses are incorporated efficiently into virus particles.
    Schnell MJ; Buonocore L; Kretzschmar E; Johnson E; Rose JK
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11359-65. PubMed ID: 8876140
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prediction and identification of a permissive epitope insertion site in the vesicular stomatitis virus glycoprotein.
    Schlehuber LD; Rose JK
    J Virol; 2004 May; 78(10):5079-87. PubMed ID: 15113889
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Studies with inhibitors of oligosaccharide processing indicate a functional role for complex sugars in the transport and proteolysis of Friend mink cell focus-inducing murine leukemia virus envelope proteins.
    Pinter A; Honnen WJ; Li JS
    Virology; 1984 Jul; 136(1):196-210. PubMed ID: 6330991
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of host ER glucosidase activity prevents Golgi processing of virion-associated bovine viral diarrhea virus E2 glycoproteins and reduces infectivity of secreted virions.
    Jordan R; Nikolaeva OV; Wang L; Conyers B; Mehta A; Dwek RA; Block TM
    Virology; 2002 Mar; 295(1):10-9. PubMed ID: 12033761
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of influenza C virus glycoprotein HEF for generation of vesicular stomatitis virus pseudotypes.
    Hanika A; Larisch B; Steinmann E; Schwegmann-Weßels C; Herrler G; Zimmer G
    J Gen Virol; 2005 May; 86(Pt 5):1455-1465. PubMed ID: 15831958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.